Journals / Turkish Journal of Veterinary and Animal Sciences / 2013 / Cilt: 37 - Sayı: 6

Clostridium botulinum in honey: prevalence and antibiotic susceptibility of isolated strains

Pages
706–711
Publication Date
2013-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results show that different types of honey are contaminated with C. botulinum and toxin types also show different distribution.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Clostridium botulinum and rare strains of C. butyricum and C. baratii produce an extremely potent toxin, the botulinum neurotoxin (BoNT).
📊
Key Findings & Data:Infant botulism is significant for both its high mortality rates and for the sophisticated treatment that it requires.
💡
Conclusion & Impact:The results show that different types of honey are contaminated with C. botulinum and toxin types also show different distribution.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Clostridium botulinum · honey · PCR

Abstract

Clostridium botulinum and rare strains of C. butyricum and C. baratii produce an extremely potent toxin, the botulinum neurotoxin (BoNT). Infant botulism is significant for both its high mortality rates and for the sophisticated treatment that it requires. Isolation and identification of C. botulinum according to standards depend on mouse bioassays to determine toxin-producing ability of strains. Polymerase chain reaction (PCR) is used to detect the types of toxins expressed by bacteria. Since honey is an important source of infant botulism, we determined the types of toxins secreted by C. botulinum strains and their antibiotic resistance. In this study, the first step was conducted to determine the prevalence of C. botulinum in different honey types; as the second step, antibiotic susceptibility of the strains was determined; and, finally, PCR typing of toxin genes was done. Nineteen strains were isolated from 250 honey samples. All C. botulinum strains were evaluated for BoNT types using PCR. BoNT type A was observed in 12 of the 19 (63.15%) strains, type B was observed in 3 (15.78%) strains, type F was recorded in 2 (10.52%) strains, and 2 of the 19 (10.52%) strains showed no amplification. All strains represented a resistance to amoxicillin and trimethoprim sulfamethoxazole (100%), followed with sulfamethoxazole and ampicillin (94.73%). Resistance to nalidixic acid was seen in 84.21%. The results show that different types of honey are contaminated with C. botulinum and toxin types also show different distribution. Additionally, antibiotic resistance patterns of the strains showed different distributions, which indicates obligatory application of antibiotic resistance testing for prevention of secondary infections.

Özet

Clostridium botulinum and rare strains of C. butyricum and C. baratii produce an extremely potent toxin, the botulinum neurotoxin (BoNT). Infant botulism is significant for both its high mortality rates and for the sophisticated treatment that it requires. Isolation and identification of C. botulinum according to standards depend on mouse bioassays to determine toxin-producing ability of strains. Polymerase chain reaction (PCR) is used to detect the types of toxins expressed by bacteria. Since honey is an important source of infant botulism, we determined the types of toxins secreted by C. botulinum strains and their antibiotic resistance. In this study, the first step was conducted to determine the prevalence of C. botulinum in different honey types; as the second step, antibiotic susceptibility of the strains was determined; and, finally, PCR typing of toxin genes was done. Nineteen strains were isolated from 250 honey samples. All C. botulinum strains were evaluated for BoNT types using PCR. BoNT type A was observed in 12 of the 19 (63.15%) strains, type B was observed in 3 (15.78%) strains, type F was recorded in 2 (10.52%) strains, and 2 of the 19 (10.52%) strains showed no amplification. All strains represented a resistance to amoxicillin and trimethoprim sulfamethoxazole (100%), followed with sulfamethoxazole and ampicillin (94.73%). Resistance to nalidixic acid was seen in 84.21%. The results show that different types of honey are contaminated with C. botulinum and toxin types also show different distribution. Additionally, antibiotic resistance patterns of the strains showed different distributions, which indicates obligatory application of antibiotic resistance testing for prevention of secondary infections.

🔖

Cite This Article

KOLUMAN, A., GÖLCÜ, B. M., DERİN, O., ÖZKÖK, S., ANNIBALLI, F. (2013). Clostridium botulinum in honey: prevalence and antibiotic susceptibility of isolated strains. Turkish Journal of Veterinary and Animal Sciences, Cilt: 37 - Sayı: 6, 706–711. https://ajindex.com/articles/121925

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Solomon HM, Lilly T Jr. Clostridium botulinum. In: US Food and Drug Administration, editor. Bacteriological Analytical Manual. 8th ed. Silver Spring, MD, USA: FDA; 2001. Chapter 17. 2001. Available at http://www.fda.gov/Food/ FoodScienceResearch/LaboratoryMethods/ucm070879.htm. Arnon SS, Midura TF, Clay RM, Wood RM, Chin J. Infant botulism: epidemiological, clinical and laboratory aspects. J Am Med Assoc 1977; 237: 1946–1951. Midura TF. Update: infant botulism. Clin Microbiol 1996; 9: 119–125.
  2. Chin J, Arnon SS, Midura TF. Food and environmental aspects of infant botulism in California. Rev Inf Dis 1979; 1: 693–696.
  3. Lonati D, Locatelli CA, Fenicia L, Anniballi F, Landri P, Giampreti A, Petrolini, VM, Vecchio S, Manzo L. Fatal course of foodborne botulism in an eight-month old infant. Pediatr Rep 2011; 3: e31. Arnon SS, Damus K, Chin J. Infant botulism: epidemiology and sudden infant death syndrome. Epidemiol Rev 1981; 3: 45– Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases, Revised Reprint, 3rd ed. Philadelphia: Churchill Livingstone, 2009.
  4. Midura TF, Snowden S, Wood RM, Arnon SS. Isolation of Clostridium botulinum from honey. J Clin Microbiol 1979; 9: 282–283.
  5. Nevas M, Lindstrom M, Hautamaki K, Puoskari S, Korkeala H. Prevalence and diversity of Clostridium botulinum types A, B, E and F in honey produced in the Nordic countries. Int J Food Microbiol 2005; 105: 145–151.
  6. Gilbert S, Lake R, Hudson A, Cressey P. Risk Profile: Clostridium botulinum in honey. Christchurch, New Zealand: Institute of Environmental Science & Research, 2006.
  7. Küplülü Ö, Göncüoğlu M, Özdemir H, Koluman A. Incidence of Clostridium botulinum spores in honey in Turkey. Food Cont 2006; 17: 222–224. Nevas M. Clostrıdium botulinum in honey production with respect to infant botulism. Academic Dissertation, Department of Food and Environmental Hygiene, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland, 2006. Available at https://helda.helsinki.fi/bitstream/ handle/10138/18964/clostrid.pdf?sequence=2. Nevas M, Lindström M, Hörman A, Keto-Timonen R, Korkeala H. Contamination routes of Clostridium botulinum in the honey production environment. Environ Microbiol 2006; 8: 1085–1094. DIN. Detection of Clostridium botulinum and Botulinum Toxin. DIN-10102. Berlin: Deutsches Insitut für Normung, 19 Dolan K. Ethics Animals and Science. Oxford: Blackwell Science, 1999.
  8. Nab J, Balls M, Hendriksen CFM. Alternatives to animal experimentation